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TO THE EDITOR
Burn-wound healing is a dynamic,
interactive process involving a number
of cellular and molecular events and
is characterized by inflammation, gra-
nulation tissue formation, re-epithe-
lialization, and tissue remodeling
(Greenhalgh, 2002; Linares, 2002). Un-
like incisional-wound healing, it also
requires extensive re-epithelialization
due to a predominant horizontal loss
of tissue and often heals with abnormalAbbreviation: 2D, two-dimensional
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scarring when burns involve deep
dermis. The early mammalian fetus
has the remarkable ability to regenerate
normal epidermis and dermis and to
heal dermal incisional wounds with no
signs of scarring. Extensive research has
indicated that scarless healing appears
to be intrinsic to fetal skin (McCallion
and Ferguson, 1996; Ferguson and
O’Kane, 2004). Previously, we reported
a fetal burn model, in which 80-day-old
ovine fetuses (gestation¼145–153
days) healed deep dermal partial thick-
ness burns without scars, whereas post-
natal lambs healed equal depth burns
with significant scarring (Cuttle et al.,
2005; Fraser et al., 2005). This burn
model provided early evidence that
fetal skin has the capacity to repair
and restore dermal horizontal loss, not
just vertical injuries.
THE PROTEOMIC PROFILING OF
FETAL AND POSTNATAL LAMB SKIN
To search for potential molecules res-
ponsible for scarless wound healing of
burns in the fetus, we initiated a
proteomic investigation of our fetal
ovine burn model. This fetal ovine burn
experiment was approved by the Uni-
versity of Queensland Animal Ethics
Committee. We used two-dimensional
(2D)-PAGE) followed by matrix-assisted
laser desorption/ionization time-of-
flight mass spectrometry. The 2D-PAGE
patterns of protein expression were
compared in four tissue samples: fetal
control and burn and lamb control and
burn (Cuttle et al., 2005; Fraser et al.,
2005). The results show that the pat-
terns of protein expression are similar
between these four types of samples,
characterized by two clusters of protein
spots, one with pI 4–6 and medium
sizes in molecular weight and another
with pI 6–10 and very low molecular
weight (Figure 1a–d). As predicted,
there are differences, such as more
protein spots with low-level expression
in postnatal skin compared to fetal skin
and the upregulation of a number of
protein spots following burn injuries.
Most noticeably, there are several
proteins that appear to be expressed in
a much higher level in fetal skin than in
lamb skin.
Mass spectrometry analysis of 2D-
PAGE spots has been widely employed
to investigate the skin proteome (Huang
et al., 2003; Liang et al., 2004; Hens-
bergen et al., 2005). These studies
profiled cultured keratinocytes and fi-
broblasts or epidermis only to examine
their response to UV radiation or to
identify the expression signatures of
epidermal stem cells. The pattern of
protein spots obtained from the in vivo
skin sample of the current study is quite
different from that seen in these earlier
studies. Nevertheless, the 2D pattern of
ovine postnatal skin sample does re-
semble that of murine skin with a
number of high-level protein spots
around pI 4–6 and medium size in
molecular weight (Huang et al., 2003).
To our knowledge, this is the first report
detailing the proteomic profiling of fetal
skin.
HIGH LEVELS OF FETUIN-A
IN OVINE FETAL SKIN
Matrix-assisted laser desorption/ioniza-
tion time-of-flight mass spectrometry
analysis identified fetuin-A as a major
component of fetal skin (Figure 1a and
b), and this was verified by western
blotting using a fetuin-A antibody
(a kind gift from Dr Dziegielewska).
Fetuin-A, also known as alpha2-HS
glycoprotein, is a product of the AHSG
gene. A search of human keratinocyte
and fibroblast databases (http://proteo-
mics.cancer.dk) failed to reveal this
protein. In the current study, fetuin-A
protein was one of the most abundant
proteins detected by silver staining and
a high level of expression was main-
tained from fetus day 81 (F81) up to
F140. After birth, fetuin-A expression
was significantly reduced (Figure 1c
and d) indicating that the high levels of
fetuin-A are intrinsic to fetal skin. The
quantitative analysis by western blot
indicated an approximately fourfold
increase in fetal control skin compared
to lamb control skin, an approximately
twofold upregulation following burn
injuries for lamb skin, and no signifi-
cant change following burn injuries for
fetal skin (Figure 1e). Earlier work has
shown that fetuin-A is mainly synthe-
sized by hepatocytes and secreted into
the peripheral blood circulation system
with the highest concentrations found
in the fetus (Pederson, 1944; Dziegie-
lewska and Brown, 1995). A recent
study detected fetuin-A in adult mouse
skin by western blotting (Denecke
et al., 2003), but we found much higher
levels in fetal ovine skin.
LOCALIZATION OF FETUIN-A
IN OVINE SKIN
To examine the significance of fetuin-A
expression in skin development and
wound healing, we investigated the
localization of fetuin-A in skin tissues.
In agreement with the 2D-PAGE analy-
sis, fetal skin expresses much higher
levels of fetuin-A than postnatal skin
(Figure 1f and n). Interestingly, in
F81–94 day fetal skin, the highest level
of fetuin-A expression was found in
keratinocytes of the epidermal basal
layer (Figure 1f), which also express
high levels of keratin 14 (Figure 1i).
Fetuin A is particularly prominent at
sites where basal keratinocytes are
reorganizing to form hair follicle pla-
codes. However, from F101 day on-
ward basal-layer expression of fetuin-A
is lost, and by day F140 only low levels
of fetuin-A are observed in the bulb
region of hair follicles and outer root
sheaths of hair follicles (data not
shown). Fetuin-A is also found at high
levels in the dermis during fetal devel-
opment (F81–140 days) and particularly
in fibroblasts under and adjacent to
the developing placode (dermal
condensate and fibrous sheath of hair
follicle).
Unlike human and rodent hair folli-
cles, the wool follicles of merino sheep
consist of primary, secondary, and
secondary-derived follicles, with the
primary and secondary hair follicles
developing at F70–90 days (Rogers,
2006). Thus, the onset of fetuin-A
expression in the basal layer of the
epidermis coincides with the initiation
of primary and secondary hair follicle
development. This may also be the case
for other mammals. For example, in
developing rat skin, fetuin-A is present
in a subset of basal layer cells at
embryo day 18 (E18) but not at
E12–16 days (Terkelsen et al., 1998).
This expression at E18 skin corresponds
to the appearance of hair germs (Gibson
et al., 1983). However, the patchy
pattern of fetuin-A expression in the
basal layer of rat skin is very different
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Figure 1. The expression of fetuin-A in skin samples. (a) The protein profiles of ovine fetal control skin at fetus 80 days, (b) ovine burned fetal skin day 1
post-burn injuries at fetus 81 days, (c) postnatal lamb control skin aged 30 days, (d) and burned postnatal lamb skin day 1 post-burn injuries aged 31 days.
Samples containing 10mg of skin protein were subjected to isoelectric focusing in linear gradient Immobiline Dry-Strips of pH 3–10, separated according to mass
via SDS-PAGE, and then silver stained. Arrows indicate fetuin-A spots, which were identified by matrix-assisted laser desorption/ionization time-of-flight mass
spectrometry and further confirmed by western blotting. (e) Western blotting of same four skin samples from above (lane 1: fetal control, 2: fetal burn, 3: lamb
control, 4: lamb burn). The total skin lysates were fractionated by SDS-PAGE and transferred to a polyvinylidine difluoride membrane. The blot was then probed
with fetuin-A antibody (Acris, Acris Antibodies) and bound antibody was visualized by secondary antibody IRDye 800 (Rockland Immunochemicals Inc.,
Rockland, NY) on ODYSSEY (LI-COR Biosciences, Lincoln, NE). It shows that fetuin-A is more highly expressed in fetal skin than in postnatal lamb skin.
(f–i) Sections (4 mm) of fetal control skin at fetus 81 days, (j–m) burned fetal skin 7 days post-burn injuries, (n–q) postnatal lamb control skin aged 37 days, and
(r–u) burned postnatal lamb skin 7 days post-burn injuries aged 37 days were treated with antibodies to (f, j, n, r) fetuin-A or (i, m, q, u) keratin 14.
(f) Bar¼ 10mm. The tissue binding of these primary antibodies are visualized with Alexa Fluor 488. 40,6-Diamidino-2-phenylindole was used for DNA staining.
Fetuin-A is highly expressed in (f) the basal layer of epidermis in fetal skin, (j, r) and in the suprabasal layer of epidermis post-burn injuries.
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from the uniform expression seen in
basal-layer keratinocytes in the current
study. This could be explained by a
number of differences in skin morpho-
logy and skin appendages between
these two species. It is well known that
the inhibition of bone morphogenetic
protein signaling in dermis and the
activation of Wnt signaling in epidermis
act in concert to induce and initiate hair
follicles (Millar, 2002; Fuchs, 2007).
Fetuin-A is a natural antagonist of bone
morphogenetic protein (Demetriou
et al., 1996), and the high levels of
fetuin-A in the dermis, particularly
surrounding developing hair placodes
and hair germs, may be indicative of a
role in regulating follicle growth and/or
initiation by modulating bone morpho-
genetic protein signaling.
FETUIN-A EXPRESSION IN BURNED
SKIN TISSUE
Although the expression level of fetuin-
A is not significantly changed following
burn injuries, its expression is clearly
upregulated in suprabasal layers of
the epidermis in both burned fetal
(Figure 1j) and postnatal lamb skin
(Figure 1r), whereas fetuin-A is unde-
tectable in the suprabasal layer of
normal control skin. This upregulation
is maintained for about 2 weeks post-
burn injury. At the same time, keratin
14 expression is seen in both basal and
suprabasal layers of epidermis (Figure
1m and u), which has been suggested
as being essential for the epidermal
integrity of healing wounds (Patel et al.,
2006). Nevertheless, dermal fetuin-A
expression after burn injury remains at
the same level and pattern. It is unclear
what role the expression of fetuin-A in
the suprabasal cells plays in this pro-
cess. As one of the mechanisms for
wound healing is the re-activation of
developmental processes (Stramer and
Martin, 2005), the appearance of
fetuin-A in these cells may reflect a




We speculate that fetuin-A may be
involved in re-epithelialization. To test
this hypothesis, we used a well-
described and widely used in vitro
wound-closure assay (Li et al., 2004;
Greenhalgh, 2005). Human foreskin
primary keratinocytes were cultured
to confluence on 24-well plates and
a cross-like wound (E1mm wide)
was created by ‘‘scraping’’ (Figure 2a).
The cultures were then incubated
in keratinocyte-serum-free media
(Invitrogen, Carlsbad, CA) with or with-
out fetuin-A. Wound closure was
monitored and quantified by image
analysis (Image Pro Plus) at 24 hours
post-wounding. The results showed a
reduction in wound size in wells con-
taining fetuin-A (Figure 2). In cultures
with 500mgml1 fetuin-A, wound
closure was most significant with nearly
80% of the wound closed, compared
to only 30% closure in cultures with-
out fetuin-A. Interestingly, enhanced
wound closure by fetuin A was due
mostly to increased cell migration
rather than to increased levels of pro-
liferation, as judged by bromodeoxy-
urine staining of cultures with fetuin A
(data not shown).
100%
0 hour 24 hours
24 hours0 hour
Fetuin-A 0 μg ml–1
















Figure 2. Fetuin-A promotes wound closure on human primary keratinocyte culture. Human foreskin
primary keratinocytes were plated in 24-well plates and allowed to proliferate to full confluence. A cross-
like wound was created and cultures were then incubated with or without fetuin-A 100 mg–10mgml1 in
keratinocyte-serum-free media. Keratinocyte-serum-free media supplemented with EGF and bovine
pituitary extract is referred to as keratinocyte complete media and is used as a positive control. At
24 hours post-wounding the wound closure was monitored and quantified by an image-analysis program.
(a) Two examples of a wound-closure assay. The dotted line indicates the areas of the wound at 0 and
24hours. (b) The quantitative analysis of keratinocyte wound closure with different concentrations of
fetuin-A. The percentage represents the area of wound closed compared with the original wound size.
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Wound re-epithelialization and
keratinocyte migration are initiated by
exposure to various growth factors and
cytokines released within wounds by
damage tissue. Earlier closure of the
wound is a desired goal in burn-wound
healing in order to minimize scarring.
The findings from the current study show
that fetuin-A is able to markedly en-
hance wound closure in primary kerati-
nocytes, and is present as a major
protein component of fetal skin. It shows
regional localization during skin devel-
opment and wound healing, suggesting
that fetuin-A plays an important role in
these processes. Moreover, fetuin A has
already been implicated in a number
of growth factors/cytokine pathways,
which are involved in inflammatory
response, granulation tissue formation,
and tissue remodeling of wound healing.
The current findings provide direct
supporting evidence that fetuin A may
contribute to scarless wound healing.
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